Welcome to LookChem.com Sign In|Join Free

CAS

  • or

586-35-6

Post Buying Request

586-35-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

586-35-6 Usage

Description

2-Bromoterephthalic acid is a white crystalline powder that serves as a vital biochemical for proteomics research. It is recognized for its significance as a raw material and intermediate in various fields, including organic synthesis, pharmaceuticals, dyes, and agrochemicals.

Uses

Used in Proteomics Research:
2-Bromoterephthalic acid is used as a biochemical for proteomics research, where it plays a crucial role in the study of proteins and their interactions within a biological system.
Used in Organic Synthesis:
2-Bromoterephthalic acid is used as an important raw material and intermediate in organic synthesis, contributing to the development of various chemical compounds and substances.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Bromoterephthalic acid is utilized as a key intermediate for the synthesis of different drugs, aiding in the development of novel therapeutic agents.
Used in Dyes:
2-Bromoterephthalic acid is employed as a vital component in the production of dyes, contributing to the creation of a wide range of colorants for various applications.
Used in Agrochemicals:
In the agrochemical industry, 2-Bromoterephthalic acid is used as a significant intermediate for the synthesis of various agrochemical products, such as pesticides and fertilizers, to enhance agricultural productivity and crop protection.

Check Digit Verification of cas no

The CAS Registry Mumber 586-35-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,8 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 586-35:
(5*5)+(4*8)+(3*6)+(2*3)+(1*5)=86
86 % 10 = 6
So 586-35-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H5BrO4/c9-6-3-4(7(10)11)1-2-5(6)8(12)13/h1-3H,(H,10,11)(H,12,13)/p-2

586-35-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A14393)  2-Bromoterephthalic acid, 97%   

  • 586-35-6

  • 5g

  • 681.0CNY

  • Detail
  • Alfa Aesar

  • (A14393)  2-Bromoterephthalic acid, 97%   

  • 586-35-6

  • 25g

  • 2275.0CNY

  • Detail
  • Alfa Aesar

  • (A14393)  2-Bromoterephthalic acid, 97%   

  • 586-35-6

  • 100g

  • 7292.0CNY

  • Detail
  • Aldrich

  • (115274)  2-Bromoterephthalicacid  95%

  • 586-35-6

  • 115274-5G

  • 574.47CNY

  • Detail
  • Aldrich

  • (115274)  2-Bromoterephthalicacid  95%

  • 586-35-6

  • 115274-25G

  • 2,990.52CNY

  • Detail

586-35-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Bromoterephthalic acid

1.2 Other means of identification

Product number -
Other names 2-bromo-1,4-dicarboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:586-35-6 SDS

586-35-6Relevant articles and documents

SUBSTITUTED TRICYCLIC COMPOUNDS

-

Page/Page column 171-172, (2021/07/02)

Disclosed are compounds of the general formula (I), its tautomeric form, its stereoisomer, its pharmaceutically acceptable salt, its polymorph, or solvate thereof, wherein, ring A, ring B, R1 to R4, and n are as defined herein, for use as SOS1 inhibitors in the treatment of proliferative, infectious and RASopathy diseases or disorders. Also disclosed are methods of synthesizing the compound of formula I, pharmaceutical compositions containing the compound of formula I, method of treatment of proliferative, infectious and RASopathy diseases or disorder, for example, a cancer, by administering the said compound and combinations of the compound of formula I with other active ingredients.

Continuous synthesis method for substituted benzoic acid organic matter

-

Paragraph 0117-0119; 0138, (2019/10/01)

The invention provides a continuous synthesis method for a substituted benzoic acid organic matter. The continuous synthesis method comprises the following steps: in the presence of a catalyst and anorganic solvent, continuously putting an organic matter of a formula (I) shown in the specification, and oxygen into a continuous reaction device, carrying out a continuous oxidation reaction so as toobtain the substituted benzoic acid organic matter, and continuously discharging the substituted benzoic acid organic matter, wherein the substituted benzoic acid organic matter is of a structure ofa formula (II) shown in the specification. Oxygen is a green reagent and is cheap and easy to obtain, a great amount of wastes are not generated after reactions are completed, and the system is easy to treat. Due to continuous reaction operation, the risk that the solvent has flash evaporation explosion because of high-concentration oxygen in in-batch reactions can be reduced. Under same oxidationconditions, due to a continuous preparation process, escape of oxygen can be reduced, the utilization rate of oxygen can be greatly increased, operation can be also simplified, the security of reactions can be improved, and the yield of the substituted benzoic acid organic matter can be increased.

Structural diversity, luminescence and photocatalytic properties of six coordination polymers based on designed bifunctional 2-(imidazol-1-yl)terephthalic acid

Zhang, Xiutang,Fan, Liming,Fan, Weiliu,Li, Bin,Liu, Guangzeng,Liu, Xinzheng,Zhao, Xian

, p. 6914 - 6925 (2016/09/23)

Six coordination polymers (CPs), {[M(ITA)]·0.5H2O}n (M = Zn 1, M = Mn 2), {[Zn(ITA)(bib)0.5]·1.5H2O}n (3), {[Ni(ITA)(bib)0.5(H2O)3]·H2O}n (4), {[Zn(ITA)(bimb)0.5]·0.5H2O}n (5) and [Cd(ITA)(bimb)0.5(H2O)2]n (6), have been derived from the designed bifunctional 2-(imidazol-1-yl)terephthalic acid (H2ITA) with or without bis(imidazole) linkers (bib = 1,4-bis(imidazol-1-yl)benzene, bimb = 1,4-bis(imidazol-1-ylmethyl)benzene). X-Ray single-crystal diffraction analysis reveals that complexes 1 and 2 are isomorphic with the same 3D (4)-connected {4·63·82} net. Complex 3 features a 3D 2-fold interpenetrated (3,4)-connected fsc net with point symbol of {4·82·103}{4·82}. Complex 4 displays a 2D 3-connected {63)-hcb sheet, which can be further expanded into a 3D supramolecular network through hydrogen bonding interactions. Complex 5 exhibits an unprecedented 3D 2-fold interpenetrated (3,4)-connected dmc net with point symbol of {4·82}{4·85}. Complex 6 shows a 3D (3,4)-connected {4·82·103}{4·82}-fsc net. Structural comparison reveals that not only the coordination preferences of metal ions but also the auxiliary bis(imidazole) linkers play crucial roles in the control of the final structures. Besides, the photoluminescence properties as well as the photocatalytic activities for the degradation of methylene blue (MB) under UV-vis light of 1, 3, 5 and 6 have been investigated.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 586-35-6